Saturday, May 29, 2010

This week Update

Some 6-7 years back I had started working in the field of Molecular Biology and Fermentas and Geneart are the acronyms in our field.....This week there were following updates.............

- Life tech has purchased Germany based Gene-art for 47M USD, Gene-art has been into synthetic DNA, duplexes and oligos for a long time and with this acquisition Life tech has acquired capabilities from initial DNA synthesis to Bio-pharmaceutical pilot scale production.

- Thermo Fischer on the other hand into Biotechnology based instruments and storage and now it has acquired Fermentas (one of the market leaders in Restriction Digestion Technology, so now Novozyme and Danisco, New england Biolabs has touch competition ahead.

Now i am awaiting news from Qiagen as it has not done any major deals this quarter compared to last year 2009

Tuesday, May 25, 2010

Last week India Pharma Review


Till yesterday I was mad at finishing our final deliverable for a short term Client project and now as had a good 8 hrs sleep after long time so I am back to my old habit of doing my favourite thing……Writing my Blog………..Last week there was a major deal in the Indian subcontinent Abbott acquisition of Nicholas , earlier there were talks of GSK’s interest in acquiring Nicholas which never came through and GSk then went into getting stakes in Dr Reddy’s , Now I am awaiting one more million dollar deal in generic market in the Indian Subcontinent from Bristol Mayer Squibb, Merck and Pfizer ..As after this deal Abbott has got strong foothold in India and its time for Big daddies to gear up for next mega deal.

Thursday, May 20, 2010

America's Most Popular drugs

Today after long time got a chance to write something for my Blog as there was a short term project going on and the file was delivered .....so now i am relaxing a bit ...............Last week and week end were quite hectic and now a days i am pursuing my passion for dance drama's .............Now about the pharma industry there were many small mergers and acquisitions in this fortnight but i am still waiting for the big players like Roche, BI, Bayer and Pfizer bigger M&A...........When i previewed the list and compared the Indian scenario i did not find a huge difference.

Today there was a update for America's Most Popular Drugs in IMS report. Following drugs are included in the list

Drug Name  Indication  Prescriptions
2009 

Hydrocodone/
acetaminophen
Pain killer  128.2 M 
Simvastatin High cholesterol 83 M
Lisinopril  High Blood Pressure 81.3 M
Levothyroxine sodium Thyroid disorders 66 M
Azithromycin Antibiotics 53.8 M
Metformin Diabetes 52 M
Lipitor High cholesterol 51.5 M
Amlodipine High blood pressure 50.9 M
Amoxicillin  Antibiotics 49.2 M
Hydrochlorothiazide High Blood Pressure 47.1 M
Omeprazole Heartburn 45.4 M
Alprazolam Anxiety 44.4 M
Furosemide  High blood pressure 42.8 M
Metoprolol tartrate  Angina
High blood pressure
40.5 M
































































































Tuesday, May 04, 2010

Jaii Hooo

Yesterday Economic times headline "Dr Reddy's, Elder Pharma and Mankind Pharma to hire 3,000 people".....According to the sources
  • Dr Reddy’s, Elder Pharma and Mankind Pharma each plan to hire 1,000 people in their marketing and sales force this year, Prabir Jha, global chief of HR at Dr Reddy’s, says the company had recruited 2,300 people last year.
  • Lupin to add  800.
  • GSK India had said it would hire about 300 people this year.......
  • Novartis has also started hiring for its CI captive office in Hyderabad and Bristol Mayer Squibb for its Mumbai corporate office.
  According to the sources Indian local drug market is growing at over 17%. “So at even 15% growth, a Rs 10,000 crore market will be created next year...........